Literature DB >> 2705922

The association of posterior capsular lens opacities with bilateral acoustic neuromas in patients with neurofibromatosis type 2.

M I Kaiser-Kupfer1, V Freidlin, M B Datiles, P A Edwards, J L Sherman, D Parry, L M McCain, R Eldridge.   

Abstract

This study of 47 patients from 11 families with neurofibromatosis type 2 (NF 2) confirms our previously reported association between posterior capsular cataract and NF 2. A highly significant statistical association was found between the presence of posterior capsular lens opacities and the presence of NF 2 as determined by magnetic resonance imaging or pathologic diagnosis. This association was not present for other types of lens opacities that could be the result of age-related or nonspecific changes. When considering the diagnosis of NF 2, this finding now makes it essential to use a careful dilated biomicroscopic examination of the lens to evaluate known, suspected, or at-risk individuals for this potentially early associated manifestation.

Entities:  

Mesh:

Year:  1989        PMID: 2705922     DOI: 10.1001/archopht.1989.01070010555030

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  19 in total

Review 1.  Neurofibromatosis type 2.

Authors:  D G Evans; M Sainio; M E Baser
Journal:  J Med Genet       Date:  2000-12       Impact factor: 6.318

Review 2.  Hippo-yap signaling in ocular development and disease.

Authors:  Matthew Lee; Navneet Goraya; Seonhee Kim; Seo-Hee Cho
Journal:  Dev Dyn       Date:  2018-04-23       Impact factor: 3.780

Review 3.  Clinical and genetic patterns of neurofibromatosis 1 and 2.

Authors:  N K Ragge
Journal:  Br J Ophthalmol       Date:  1993-10       Impact factor: 4.638

4.  Comparative genomic hybridization and mutation analyses of sporadic schwannomas.

Authors:  Takayuki Ikeda; Sho Hashimoto; Shinichi Fukushige; Hiroaki Ohmori; Akira Horii
Journal:  J Neurooncol       Date:  2005-05       Impact factor: 4.130

5.  Retinal changes associated with neurofibromatosis 2.

Authors:  S M Meyers; F A Gutman; L D Kaye; A D Rothner
Journal:  Trans Am Ophthalmol Soc       Date:  1995

6.  High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas.

Authors:  A B Bianchi; S I Mitsunaga; J Q Cheng; W M Klein; S C Jhanwar; B Seizinger; N Kley; A J Klein-Szanto; J R Testa
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

Review 7.  Optimizing biologically targeted clinical trials for neurofibromatosis.

Authors:  David H Gutmann; Jaishri O Blakeley; Bruce R Korf; Roger J Packer
Journal:  Expert Opin Investig Drugs       Date:  2013-02-21       Impact factor: 6.206

8.  Ocular fundus in neurofibromatosis type 2.

Authors:  K Landau; G M Yaşargil
Journal:  Br J Ophthalmol       Date:  1993-10       Impact factor: 4.638

9.  A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counselling.

Authors:  D G Evans; S M Huson; D Donnai; W Neary; V Blair; V Newton; T Strachan; R Harris
Journal:  J Med Genet       Date:  1992-12       Impact factor: 6.318

10.  Lens opacities in neurofibromatosis 2: further significant correlations.

Authors:  E A Bouzas; V Freidlin; D M Parry; R Eldridge; M I Kaiser-Kupfer
Journal:  Br J Ophthalmol       Date:  1993-06       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.